Arena Pharmaceuticals Inc., which advances small molecule drugs for varied therapeutic applications, recently announced an upcoming corporate update slated for 9 a.m. Jan. 12 at a California conference and planned for immediate online public availability.
Amit Munshi, president and CEO at the San Diego and Switzerland-based firm, will speak at the 35th Annual J.P. Morgan Healthcare Conference, scheduled at the Westin St. Francis in San Francisco.
The program will be accessible on Arena’s website both in real time and for a total of 30 days following the event. Viewers planning to hear the original webcast are instructed to navigate to the site’s investor relations section.
Additionally, listeners should connect to the company’s website prior to the 9 a.m. start time in order to accommodate any extra time needed for software downloads.
Arena Pharmaceuticals’ European operations are based in Switzerland, with clinical operations in Zug and commercial manufacturing in Zofingen. The group concentrates on solutions for ulcerative colitis, Crohn’s disease and pulmonary arterial hypertension (PAH).
The company collaborates with several other pharmaceutical businesses, including Eisai Co. Ltd. and Eisai Inc. for commercial stage use; Axovant Sciences Ltd. for phase 2 candidate work; and Boehringer Ingelheim International for preclinical candidate medications.
The three-day San Francisco Conference will run Jan. 9-12.
